Latest filing published 11 Mar 2022 for Arena Pharmaceuticals INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Joan Schmidt on record concern Arena Pharmaceuticals Inc, in the capacity of chief executive. Over a trading history stretching from 3 January 2022 to 11 March 2022, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 11 March 2022 came the latest disclosure, a transaction in Arena Pharmaceuticals Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations